Elizabeth Registry for Low Grade Ovarian Cancer

Completed

Conditions studied: Ovarian Cancer

In brief

Long-Term Objectives: * To establish an ongoing national research registry of epidemiologic, clinical and pathologic data on low grade and low malignant potential (LMP) ovarian cancer patients in UTMDACC's Department of Gynecologic Oncology for research purposes. * To create a bank of low grade and LMP ovarian cancer tumor blocks for study of the molecular and histopathologic differences among low grade ovarian cancer, ovarian LMP tumors and high grade ovarian cancer. * To specify the epidemiologic and clinical profile of low grade and LMP ovarian cancer patients. * To identify potential precursors of low grade and LMP ovarian cancer. * To assess treatment patterns to guide management of these diseases. * To collect quality of life and health outcomes data on these patients. * To achieve a fundamental understanding of low grade and LMP ovarian cancer that will inform prevention and screening efforts, motivate development of improved treatments and eventually result in a cure. The short-term objectives are: * To detail procedures for potential registrant identification and recruitment. * To create a demographic and health history questionnaire for potential registrants. * To begin aggregating low grade and low malignant potential ovarian tumor blocks. * To specify a timeline for the development of all other aspects of the Registry.

Key facts

Study ID

NCT00345709

Run by

M.D. Anderson Cancer Center

People needed

60

Starts

2003-09-01

Expected to finish

2014-10-01

Last updated by the study team

2015-10-07

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• UTMDACC patient, living or deceased, with a pathologically-confirmed diagnosis of either low grade ovarian carcinoma or LMP ovarian carcinoma.
• Able to speak and read English (for patients who are living).
• Residence in the United States, both at time of original diagnosis and at time of accession to the Registry.

You may not qualify if…

• UTMDACC patients, living or deceased, whose diagnosis of either low grade ovarian carcinoma or LMP ovarian carcinoma has not been confirmed pathologically.
• Any type of ovarian cancer other than low grade or LMP ovarian carcinoma.
• Unable to speak and read English (for patients who are living).
• Residence outside the United States, either at time of original diagnosis or at time of accession to the Registry.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.